HARRISBURG, Pa., Sept. 1, 2011
PA Healthcare facilities' CLABSI data provides focus for prevention strategies
HARRISBURG, Pa., Sept. 1, 2011/PRNewswire-USNewswire/ -- Data submitted by Pennsylvania hospitals in 2010 pinpoints timelines for prevention strategies for reducing and/or eliminating central-line-associated bloodstream infections (CLABSI), according to information published in the September 2011Pennsylvania Patient Safety Advisory.
Central venous catheters (CVC) are used as one form of access to a patient's veins for medications and other fluids. While CVCs are necessary, their use puts patients at risk for CLABSI.
Infection can occur within the first five days of insertion, known as the insertion phase, or after the first five days, which is known as the maintenance phase. Â
The Pennsylvania Patient Safety Authority studied CLABSI data reported by Pennsylvania healthcare facilities in calendar year 2010. The data showed that in over 70 percent of the CLABSI cases, the infections occurred more than five days after the CVC was placed in the patient. Infections from bacteria occurring after five days may signify weaknesses in the maintenance phase of monitoring CVCs.
"Authority analysis shows that facilities may want to consider focusing more resources on the maintenance phase of CVCs to help reduce CLABSIs," James Davis, BSN, RN, CCRN, CIC, analyst for the Pennsylvania Patient Safety Authority said. "Infection preventionists, who detailed their descriptions of the CLABSI events by providing CVC insertion dates, helped the Authority determine that most cases of CLABSI in Pennsylvania healthcare facilities developed during the maintenance phase.
"Pennsylvania hospitals should take another look at how their resources for preventing CLABSIs are being used and perhaps reallocate them based upon this new information," Davis added. "Of course, continuing best practices and compliance monitoring during the insertion phase should also remain in the prevention plan."
To help Pennsylvania hospitals assess their overall CLABSI prevention programs, the Authority provides a CLABSI prevention toolkit, available on its website at www.patientsafetyauthority.org; click on "Educational Tools." CLABSI consumer tips are also available for patients and caregivers.
For more information on the methodology used for the data analysis and to read the complete Advisory article go to "Central-Line-Associated Bloodstream Infection: Comprehensive, Data-Driven Prevention" on the Authority's website under Patient Safety Advisories September 2011. Â
The Authority's 2011 September Advisory also contains other clinical articles with toolkits for the healthcare provider to improve patient safety. Highlights include:
A Review of Medication Errors in Ambulatory Surgery Facilities (ASFs): Motivated by the lack of medical literature that quantitatively addresses medication errors occurring in ambulatory surgical settings, analysts reviewed medication errors reported to the Pennsylvania Patient Safety Authority and determined the most common error types, patient populations and medications involved. Pennsylvania ambulatory surgery facilities (ASFs) submitted 502 medication error reports to the Authority from June 28, 2004, through December 31, 2010. The most common types of medication errors reported by ASFs included drug omission, wrong drug and monitoring error/documented allergy. More than one-third of intravenous wrong-drug events involved high-alert medications. Strategies to prevent wrong-drug errors, especially for high-alert medications, are provided in this Advisory article "Ambulatory Surgery Facilities: A Comprehensive Review of Medication Error Reports in Pennsylvania."
For the complete 2011 September Pennsylvania Patient Safety Advisory, go to www.patientsafetyauthority.org.
SOURCE Pennsylvania Patient Safety AuthorityPR Newswire
Last updated on: 01/09/2011